SCHEMBL4776020

SCHEMBL4776020

NC(=O)C(Cc1c[nH]c2ccccc12)Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.49
CCND1 P24385 1/20 0.49
AKT1 P31749 4/20 0.46
HPGDS O60760 2/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
SCN9A Q15858 1/20 0.43
ITGB2 P05107 2/20 0.43
ICAM1 P05362 2/20 0.43
ITGAL P20701 2/20 0.43
MC5R P33032 2/20 0.42
MC1R Q01726 2/20 0.42
ECE1 P42892 1/20 0.42
SYK P43405 1/20 0.42
SSTR1 P30872 1/20 0.42
SSTR2 P30874 1/20 0.42
SSTR4 P31391 1/20 0.42
SSTR3 P32745 1/20 0.42
SSTR5 P35346 1/20 0.42
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4768727 0.90 TDP1 (0.51) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4766503 0.87 CDK4 (0.47) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4773620 0.87 CDK4 (0.47) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4766487 0.87 CDK4 (0.47) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4775038 0.87 CDK4 (0.47) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4776165 0.82 CCKBR (0.52) CDK4CCND1KMT2AMEN1HTT
SCHEMBL2240341 0.82 CDK4 (0.50) CDK4CCND1AKT1KMT2AMEN1
SCHEMBL4766345 0.82 CYP2A6 (0.46) KMT2ASCN9ASYKSMN1; SMN2
SCHEMBL4766379 0.82 CYP2A6 (0.46) KMT2ASCN9ASYKSMN1; SMN2
SCHEMBL4769102 0.81 KMT2A (0.55) CDK4CCND1KMT2AMEN1SYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed